Besides gliomas, IDH mutations also occur in other non-central nervous system (CNS) malignancies, including acute myeloid leukemia (AML) [3,4], intrahepatic cholangiocarcinoma [5,6], chondrosarcoma [7], and melanoma [8,9]. This evidence concerns the gene IDH2 and central nervous system cancer.